A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2.
Fulford TS, Van H, Gherardin NA, Zheng S, Ciula M, Drummer HE, Redmond S, Tan HX, Boo I, Center RJ, Li F, Grimley SL, Wines BD, Nguyen THO, Mordant FL, Ellenberg P, Rowntree LC, Kedzierski L, Cheng AC, Doolan DL, Matthews G, Bond K, Hogarth PM, McQuilten Z, Subbarao K, Kedzierska K, Juno JA, Wheatley AK, Kent SJ, Williamson DA, Purcell DFJ, Anderson DA, Godfrey DI.
Fulford TS, et al. Among authors: hogarth pm.
EBioMedicine. 2021 Dec;74:103729. doi: 10.1016/j.ebiom.2021.103729. Epub 2021 Dec 3.
EBioMedicine. 2021.
PMID: 34871960
Free PMC article.